Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 269-273

  Abkowitz, Janis L ^a   Brown, Kevin E ^b   Wood, Robert W ^b   Kovach, Nicholas L ^b   Green, Spencer W ^b   Young, Neal S ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN M; VIRUS CAPSID ANTIGEN; VIRUS DNA; ZIDOVUDINE;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; HEMATOCRIT; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; RISK FACTOR; VIREMIA; VIRUS TITRATION;

EID: 0030917310     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517264     Document Type: Article

References (16)

1. Hoxie JA. Hematologic manifestations of AIDS. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al. Hematology. Basic principles and practice. 2nd ed. New York: Churchill Livingstone, 1995:2171-200.
2. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-33.
3. Brown KE, Young NS. Persistent parvovirus B19 infection. Rev Med Microbiol 1995;6:246-56.
4. Naides SJ, Howard EJ, Swack NS, True CA, Stapleton JT. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis 1993;168:101-5 [comments, J Infect Dis 1994;169:938-40].
5. Naides SJ, Howard EJ, Swack NS, True CA, Stapleton JT. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis 1993;168:101-5 [comments, J Infect Dis 1994;169:938-40].
6. Chernak E, Dubin G, Henry D, et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;20:170-3.
7. Gyllensten K, Sonnerborg A, Jorup-Ronstrom C, Halvarsson M, Yun Z. Parvovirus B19 infection in HIV-1 infected patients with anemia. Infection 1994;22:356-8.
8. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
9. Clewley JP. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 1989;27:2647-51.
10. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36.
11. Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol 1994;87:818-24.
12. Cohen BJ, Mortimer PP, Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg 1983;91:113-30.
13. HIV/AIDS Quarterly Epidemiology Report. 2nd Quarter. Seattle, WA: Seattle-King County Department of Health, 1996.
14. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360-3.
15. Musiani M, Zerbini M, Gentilomi G, et al. Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients. J Med Virol 1995;46:103-8.
16. Patou G, Pillay D, Myint S, Pattison J. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol 1993;31:540-6.